2022
Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery
Phung M, Webb P, DeFazio A, Fereday S, Lee A, Bowtell D, Fasching P, Goode E, Goodman M, Karlan B, Lester J, Matsuo K, Modugno F, Brenton J, Van Gorp T, Pharoah P, Schildkraut J, McLean K, Meza R, Mukherjee B, Richardson J, Grout B, Chase A, Deurloo C, Terry K, Hanley G, Pike M, Berchuck A, Ramus S, Pearce C, Consortium O. Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery. Gynecologic Oncology 2022, 168: 68-75. PMID: 36401943, PMCID: PMC10398872, DOI: 10.1016/j.ygyno.2022.10.018.Peer-Reviewed Original ResearchConceptsHigh-grade serous ovarian cancerEstrogen-only therapyPrimary cytoreductive surgeryMacroscopic residual diseaseResidual diseaseParous womenFamily history of ovarian cancerOvarian Cancer Association ConsortiumMenopausal hormone therapy useHistory of ovarian cancerFirst-degree family historyCytoreductive surgeryOvarian cancer riskOvarian cancerAdvanced stage high-grade serous ovarian cancerPresence of macroscopic residual diseaseHormone therapy useHigh-grade serous ovarian cancer patientsDepot medroxyprogesterone acetate useBody mass indexLogistic regression modelsOral contraceptive useIncomplete pregnanciesSerous ovarian cancerFactors influencing survival
1999
The impact of splenectomy on outcomes after resection of pancreatic adenocarcinoma11No competing interests declared.
Schwarz R, Harrison L, Conlon K, Klimstra D, Brennan M. The impact of splenectomy on outcomes after resection of pancreatic adenocarcinoma11No competing interests declared. Journal Of The American College Of Surgeons 1999, 188: 516-521. PMID: 10235580, DOI: 10.1016/s1072-7515(99)00041-1.Peer-Reviewed Original ResearchConceptsImpact of splenectomyPancreatic cancerTumor diameterMedian postoperative length of stayPathological lymph node statusPrognostic factors influencing survivalResection of pancreatic adenocarcinomaMemorial Sloan-Kettering Cancer CenterPostoperative length of stayMaximal tumor diameterMedian actuarial survivalMedian transfusion requirementLymph node statusOperative blood lossPortal vein invasionResection of esophagealExocrine pancreatic cancerFactors influencing survivalProspective clinical databaseLength of stayActuarial survivalDisease-related factorsConcomitant splenectomyCurative intentNode status
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply